ARCAPTA NEOHALER vs INCRUSE ELLIPTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. ARCAPTA NEOHALER and INCRUSE ELLIPTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ARCAPTA NEOHALER	INCRUSE ELLIPTA
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	INDACATEROL MALEATE	UMECLIDINIUM BROMIDE
Manufacturer	Novartis	Glaxo Grp England
Dosage forms	Powder	Spray/Inhaler
Drug class	—	—
Boxed warning	None	None
Treats	Pulmonary Emphysema, Chronic Bronchitis	Pulmonary Emphysema, Chronic Bronchitis

arcapta neohaler incruse ellipta

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

INDACATEROL MALEATE

UMECLIDINIUM BROMIDE

Manufacturer

Novartis

Glaxo Grp England

Dosage forms

Powder

Spray/Inhaler

Drug class

—

Boxed warning

None

Treats

Pulmonary Emphysema, Chronic Bronchitis

Frequently asked questions

What is the difference between Arcapta Neohaler and Incruse Ellipta?

Arcapta Neohaler contains Indacaterol Maleate, while Incruse Ellipta contains Umeclidinium Bromide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.